Literature DB >> 20860090

Upregulation of thymidine kinase activity compensates for loss of thymidylate synthase activity in Mycoplasma pneumoniae.

Liya Wang1, Claudine Hames, Sebastian R Schmidl, Jörg Stülke.   

Abstract

Thymidylate, an essential building block of DNA, is synthesized either from deoxyuridylate by thymidylate synthase (TS) or thymidine (dT) by thymidine kinase (TK). Thymidylate kinase (TMPK) phosphorylates dTMP to dTTP. Thymidine phosphorylase (TP) catalyses reversible phosphorolysis of dT. Using transposon mutagenesis M. pneumoniae TS gene (thyA/MPN320) was interrupted and requirement of these enzymes was studied. We found that TK activity and transcript levels and TP activity, but not TMPK or TS activity, are growth-phase-regulated, with induction at the exponential growth phase and a decline after the stationary phase. Inactivation of thyA results in upregulation of TK transcript and a 10-fold increase in TK activity, reduced TMPK level and it had no effect on TP activity. The level of [3H]-dT uptake and incorporation into DNA in the thyA mutant correlates with increases in TK activity, suggesting that dT uptake and metabolism is TK-dependent and that upregulation of TK activity in the thyA mutant compensates for the lack of ThyA activity. [3H]-dU uptake was low compared with dT, and incorporation of radioactivity into DNA in the thyA mutant indicates the presence of an alternative TS. Our results suggest that TK and TMPK are potential targets for the development of Mycoplasma-specific antibiotics.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20860090     DOI: 10.1111/j.1365-2958.2010.07298.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  5 in total

1.  Biochemical Characterizations of Human TMPK Mutations Identified in Patients with Severe Microcephaly: Single Amino Acid Substitutions Impair Dimerization and Abolish Their Catalytic Activity.

Authors:  Junmei Hu Frisk; Jo M Vanoevelen; Jörgen Bierau; Gunnar Pejler; Staffan Eriksson; Liya Wang
Journal:  ACS Omega       Date:  2021-12-06

Review 2.  Mycoplasmas and cancer: focus on nucleoside metabolism.

Authors:  Johan Vande Voorde; Jan Balzarini; Sandra Liekens
Journal:  EXCLI J       Date:  2014-03-27       Impact factor: 4.068

3.  Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs.

Authors:  Ren Sun; Liya Wang
Journal:  BMC Microbiol       Date:  2013-08-06       Impact factor: 3.605

Review 4.  Potential Molecular Targets for Narrow-Spectrum Agents to Combat Mycoplasma pneumoniae Infection and Disease.

Authors:  Mitchell F Balish; Steven L Distelhorst
Journal:  Front Microbiol       Date:  2016-02-25       Impact factor: 5.640

5.  Inactivation of the Thymidylate Synthase thyA in Non-typeable Haemophilus influenzae Modulates Antibiotic Resistance and Has a Strong Impact on Its Interplay with the Host Airways.

Authors:  Irene Rodríguez-Arce; Sara Martí; Begoña Euba; Ariadna Fernández-Calvet; Javier Moleres; Nahikari López-López; Montserrat Barberán; José Ramos-Vivas; Fe Tubau; Carmen Losa; Carmen Ardanuy; José Leiva; José E Yuste; Junkal Garmendia
Journal:  Front Cell Infect Microbiol       Date:  2017-06-20       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.